Starling Oncology (STLN) Share-based Compensation Growth (1y) (2022 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) Share-based Compensation Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.73 Bn | 89.71 Bn | 15.19 Bn | -14.14% |
| 2 | Tenet Healthcare | 22.05 Bn | 19.88 Bn | 4.45 Bn | -133.33% |
| 3 | Encompass Health | 12.13 Bn | 12.00 Bn | 1.34 Bn | - |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | -97.96% |
| 5 | Universal Health Services | 10.12 Bn | 9.98 Bn | 3.29 Bn | 1,185.16% |
| 6 | Ensign | 9.97 Bn | 9.64 Bn | 306.24 Mn | -30.87% |
| 7 | Chemed | 6.91 Bn | 6.87 Bn | 221.47 Mn | 115.74% |
| 8 | Pacs | 6.73 Bn | 6.57 Bn | 338.46 Mn | 89.89% |
| 9 | Concentra Group Holdings Parent | 4.30 Bn | 4.14 Bn | 192.10 Mn | 80.74% |
| 10 | Starling Oncology | 613.55 Mn | 572.46 Mn | 27.17 Mn | 42.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.29% |
| Mar 31, 2026 | 15.64% |
| Dec 31, 2025 | 2.17% |
| Sep 30, 2025 | -57.14% |
| Jun 30, 2025 | -77.80% |
| Mar 31, 2025 | -64.33% |
| Dec 31, 2024 | -68.40% |
| Sep 30, 2024 | -48.72% |
| Jun 30, 2024 | -17.53% |
| Mar 31, 2024 | -17.68% |
| Dec 31, 2023 | -32.80% |
| Sep 30, 2023 | -28.83% |
| Jun 30, 2023 | -36.95% |
| Mar 31, 2023 | -41.95% |
| Dec 31, 2022 | -75.11% |
| Sep 30, 2022 | 10,994.92% |
| Jun 30, 2022 | 12,672.55% |
| Mar 31, 2022 | 20,264.29% |